From studies on colorectal cancer risk factors to research on outpatient colonoscopies, here are nine recent studies catching the eyes of gastroenterologists:
GI & Endoscopy
Motus GI shared its fourth-quarter and full-year 2020 financial results, posting a $19.3 million net loss for the year, or a $0.60 loss per diluted share.
GI OnDemand, a joint venture between the American College of Gastroenterology and Gastro Girl, partnered with Ambry Genetics on genetic counseling and testing.
Douglas Adler, MD, is joining Colorado Springs-based Peak Gastroenterology Associates and will start in April.
CRH Medical reported an uptick in fourth-quarter revenue in 2020 compared to 2019, but saw a year-over-year drop in the first through third quarters of 2020.
Advertisement
The FDA granted Check-Cap's C-Scan an investigational device exemption March 15 that will allow the test to launch a clinical study in the U.S.
A blood-based colorectal cancer test was found to be the most cost-effective alternative colorectal cancer test for people who didn't want a colonoscopy or fecal immunochemical test, according to a study published in the Journal of the National Cancer Institute.
Dallas-based GI Alliance is the biggest private equity-backed gastroenterology platform in the U.S.
Seattle-based Virginia Mason Franciscan Health is taking over a space vacated by Seattle-based Swedish Health and will open a specialty clinic to provide primary, specialty, internal medicine, laboratory and limited radiology services, West Seattle Blog reported March 12.
CRH Medical ended 2020 almost losing its largest client, but has since recovered and started 2021 with a boom.